FDA PMA Approved 🇺🇸 United States

Pulmonary Valve Prosthesis Percutaneously Delivered

PMA: P200015 · Decision Aug 31, 2020
Classifications
1
FEI Numbers
14
Registration Numbers
14

Basic Information

Device Name
Pulmonary Valve Prosthesis Percutaneously Delivered
Trade Name
Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System
PMA Number
P200015
Product Code
NPV
Generic Name
Pulmonary valve prosthesis percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
August 31, 2020
Date Received
March 9, 2020
Expedited Review
N
Docket Number
20M-1835

Advisory Committee Statement

Approval for the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System with Commander Delivery System is indicated for use in the management of pediatric and adult patients who have a clinical indication for intervention on a dysfunctional right ventricular outflow tract (RVOT) conduit or surgical bioprosthetic valve in the pulmonic position with greater than or equal to moderate regurgitation and/or a mean RVOT gradient of greater than or equal to 35 mmHg.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPV Pulmonary Valve Prosthesis Percutaneously Delivered